The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.175
Bid: 1.15
Ask: 1.20
Change: 0.00 (0.00%)
Spread: 0.05 (4.348%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.175
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects

25 Oct 2019 12:56

Hardman & Co Research Hardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects 25-Oct-2019 / 12:56 GMT/BST


Hardman & Co Research: Recent major contract wins transform prospects

ST's results, announced 9 September, were in line with expectations. Since then, ST has secured a further £0.4m revenue, prompting us to upgrade FY19 PBT estimates by £0.25m. Historical results do not reflect a series of substantial new contracts won, post May 2019 year-end, which have transformed the company. It now has multi-year, multi-million, recurring income contracts from Europeanbased global OEMs. Revenue from one commences October 2021, with start of production (SOP) for the other towards the end of calendar 2021. These will support EBITDA-positive (post-tax credit) for 2020 and profitability in 2022. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/recent-major-contract-wins-transform-prospects/

 

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contacts:

Mike Foster 

+44 20 20 7451 7050

 

mf@hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

897473 25-Oct-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
15th Sep 20207:00 amRNSCorporate presentation
14th Sep 20207:00 amRNSContract Award from OEM 8 and Trading Update
31st Jul 20203:35 pmRNSHolding(s) in Company
24th Jul 20206:28 pmRNSResult of Annual General Meeting
20th Jul 20207:00 amRNSTrading Statement & Investor Presentation
2nd Jul 20207:00 amRNSChange of Adviser
26th Jun 202010:31 amRNSPosting of Annual Report and Notice of AGM
25th Jun 20207:00 amRNSPDMR Dealing
22nd Jun 20207:00 amRNSPreliminary Results and Notice of AGM
17th Jun 20207:00 amRNSReporting timetable
8th Jun 20207:00 amRNSKoenigsegg Contract Award
1st Jun 202011:47 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSDirector Dealing
29th May 20204:51 pmRNSHolding(s) in Company
29th May 20201:17 pmRNSHolding(s) in Company
26th May 20204:01 pmRNSHolding(s) in Company
21st May 20209:30 amRNSResult of General Meeting and TVR
18th May 20207:00 amRNSResult of Excess Open Offer
5th May 20208:30 amRNSLetter to Shareholders & Notice of GM
4th May 20207:00 amRNSOpen Offer Excess
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1
19th Sep 20197:00 amRNSCapital Markets Day
18th Sep 201910:50 amRNSHolding(s) in Company
9th Sep 20197:00 amRNSPreliminary results and notice of AGM
5th Sep 20194:10 pmEQSHardman & Co Research: Surface Transforms (SCE): Rapid acceleration - 'game-change' announcements
27th Aug 20197:00 amRNSContract Agreement with German OEM 5
15th Aug 20197:00 amRNSChange of Financial Year End Date
16th Jul 20197:00 amRNSContract award from German OEM 5
28th Jun 20197:00 amRNSContract Awards and Commercial Settlement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.